Cited by 1,102Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.

Human Cannabinoid Pharmacokinetics

Open access

Huestis, Marilyn A.·2007·Chemistry & Biodiversity

DOI 10.1002/cbdv.200790152PMC PMC2689518

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1002/cbdv.200790152

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,514
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
Cannabis: pharmacology and toxicology in animals and humans
Adams, I. B., & Martin, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 576
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J., Brown, P., Pertwee, R., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 546

Flagged first, then by citations

Show all 173 references

Research works printed but not linked: 26

Agurell S., 1971, Acta Pharm. Suecica, 8, 391
Agurell S., 1986, Pharmacol. Rev., 38, 21
Azorlosa J. L., 1992, J. Pharmacol. Exper. Ther., 261, 114
Perez‐Reyes M., 1990, NIDA Res. Monograph, 99, 42
Harder S., 1997, Int. J. Clin. Pharmacol. Ther., 35, 155
Ohlsson A., 1981, NIDA Res. Monograph, 34, 250
Meier H. J., 1997, Schweiz. Med. Wochenschr., 127, 214
Brenneisen R., 1996, Int. J. Clin. Pharmacol. Ther., 34, 446
Vinciguerra V., 1988, N. Y. State J. Med., 88, 525
McArdle K., 2001, Toxicology, 168, 133
Garrett E. R., 1978, Adv. Biosci., 22, 105
Hunt C. A., 1980, J. Pharmacol. Exper. Ther., 215, 35
Lee C. C., 1985, NIDA Res. Monograph, 60, 110
Martin B. R., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 457
Ben‐Zvi Z., 1974, Res. Commun. Chem. Pathol. Pharmacol., 8, 223
Harvey D. J., 1986, Rev. Biochem. Toxicol., 6, 221
Bornheim L. M., 1992, Drug Metab. Dispos., 20, 241
Halldin M. M., 1982, Drug Metab. Dispos., 10, 297
Chiang C. N., 1987, NIDA Res. Monograph
Bloom A. S., 1982, J. Pharmacol. Exper. Ther., 221, 97
Green M. D., 1997, Drug Metab. Dispos., 25, 1389
Mura P., 1999, Acta Clin. Belg., 1, 35
Soares J. R., 1982, NIDA Res. Monograph, 42, 44
Hawks R. L., 1982, NIDA Res. Monograph, 42, 125
Huestis M. A., 1992, Am. Acad. Forensic Sci. Annual Meeting, 190
Balabanova S., 1989, Beitr. Gerichtl. Med., 48, 45

Sorted by citations

Items 401–500 of 1,000

Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
Batinić, A., Sutlović, D., Kuret, S., Burčul, F., Kalajžić, N., Matana, A., Dujić, G., Vrdoljak, J., Kumrić, M., Božić, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210273 · Cited by 23
The cannabinoid acids, analogs and endogenous counterparts
BURSTEIN, S. H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.038 · Cited by 23
Beyond the Bud
Struble, C. A., Ellis, J. D., & Lundahl, L. H. (2019) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2019.08.012 · Cited by 23
An evaluation of postmortem concentrations of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH)
Hoffman, M. A., Trochta, A., Gary, R. D., Fitzgerald, R. L., & McIntyre, I. M. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110414 · Cited by 23
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial
Lavender, I., McCartney, D., Marshall, N. S., Suraev, A. S., Irwin, C. G., D'Rozario, A. L., Gordon, C. J., Saini, B., Grunstein, R. R., Yee, B. J., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071148 · Cited by 22
Chronic cannabis use and ERP correlates of visual selective attention during the performance of a flanker go/nogo task
Nicholls, C., Bruno, R., & Matthews, A. J. (2015) · Biological Psychology · doi:10.1016/j.biopsycho.2015.07.013 · Cited by 27
Cannabis for paediatric epilepsy: challenges and conundrums
Chen, K., Farrar, M. A., Cardamone, M., & Lawson, J. A. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00699 · Cited by 24
Surface Detection of THC Attributable to Vaporizer Use in the Indoor Environment
Sempio, C., Lindley, E. M., Klawitter, J., Christians, U., Bowler, R. P., Adgate, J. L., Allshouse, W. B., Awdziejczyk, L., Fischer, S. N., Bainbridge, J. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55151-5 · Cited by 22
Cannabis-impaired driving and Canadian youth
Brubacher, J. R., Chan, H., & Staples, J. A. (2020) · Paediatrics & Child Health · doi:10.1093/pch/pxaa017 · Cited by 23
Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
Busardò, F. P., Pérez-Acevedo, A. P., Pacifici, R., Mannocchi, G., Gottardi, M., Papaseit, E., Pérez‐Mañá, C., Martín, S., Poyatos, L., Pichini, S., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14010059 · Cited by 22
A mixed-methods study to inform the clarity and accuracy of cannabis-use and cannabis-tobacco co-use survey measures
Watkins, S. L., Karliner-Li, P., Lee, Y. O., Koester, K. A., & Ling, P. M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108697 · Cited by 22
Current Cannabidiol Safety: A Review
Singh, C., Rao, K., Yadav, N., Vashist, Y., Chugh, P., Bansal, N., & Minocha, N. (2022) · Current Drug Safety · doi:10.2174/1574886317666220902100511 · Cited by 22
Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment
Dumbraveanu, C., Strommer, K., Wonnemann, M., Choconta, J. L., Neumann, A., Kress, M., Kalpachidou, T., & Kummer, K. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030853 · Cited by 22
Therapeutic Potential of Cannabinoids in Glaucoma
Lindner, T., Schmidl, D., Peschorn, L., Pai, V., Popa‐Cherecheanu, A., Chua, J., Schmetterer, L. F., & Garhöfer, G. (2023) · Pharmaceuticals · doi:10.3390/ph16081149 · Cited by 23
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of “Light Cannabis” Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use
Pichini, S., Mannocchi, G., Berretta, P., Zaami, S., Pirani, F., Pacifici, R., & Busardò, F. P. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000683 · Cited by 22
Delays in DUI blood testing: Impact on cannabis DUI assessments
Wood, E., Brooks‐Russell, A., & Drum, P. (2015) · Traffic Injury Prevention · doi:10.1080/15389588.2015.1052421 · Cited by 22
Cannabis Use Surveillance by Sweat Analysis
Gambelunghe, C., Fucci, N., Aroni, K., Bacci, M., Marcelli, A., & Rossi, R. (2016) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000327 · Cited by 22
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
Fitzcharles, M., & Häuser, W. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0625-5 · Cited by 24
Effects of tetrahydrocannabinol on glucose uptake in the rat brain
Miederer, I., Uebbing, K., Röhrich, J., Maus, S., Bausbacher, N., Krauter, K., Weyer‐Elberich, V., Lutz, B., Schreckenberger, M., & Urban, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.011 · Cited by 23
Cannabis edibles: dosing, encapsulation, and stability considerations
Marangoni, I. P., & Marangoni, A. G. (2019) · Current Opinion in Food Science · doi:10.1016/j.cofs.2019.01.005 · Cited by 21
Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns
Dabiri, A. E., & Kassab, G. S. (2021) · Medical Cannabis and Cannabinoids · doi:10.1159/000519775 · Cited by 21
Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Vinci, A., Ingravalle, F., Bardhi, D., Cesaro, N., Frassino, S., Licata, F., & Valvano, M. (2022) · Biomedicines · doi:10.3390/biomedicines10102439 · Cited by 22
Maternal Cannabis Use during Lactation and Potential Effects on Human Milk Composition and Production: A Narrative Review
Castro, I., McGuire, M. A., Williams, J. E., Holdsworth, E. A., Meehan, C. L., & McGuire, M. K. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100196 · Cited by 23
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Stasiłowicz-Krzemień, A., Nogalska, W., Maszewska, Z., Maleszka, M., Dobroń, M., Szary, A., Kępa, A., Żarowski, M., Hojan, K., Łukowicz, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115749 · Cited by 28
Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats
Barrus, D. G., Lefever, T. W., & Wiley, J. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.018 · Cited by 21
Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
Krämer, M., Madea, B., & Heß, C. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2682 · Cited by 21
Analysis of cannabinoids in urine samples of short-term and long-term consumers of hemp seed products
Baeck, S., Kim, B.-J., Cho, B., & Kim, E. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.109997 · Cited by 21
Cannabinoids in the Treatment of Back Pain
Kim, T. E., Townsend, R. K., Branch, C. L., Romero-Sandoval, E. A., & Hsu, W. (2020) · Neurosurgery · doi:10.1093/neuros/nyz573 · Cited by 21
Reelin deficiency contributes to long-term behavioral abnormalities induced by chronic adolescent exposure to Δ9-tetrahydrocannabinol in mice
Iemolo, A., Montilla‐Perez, P., Nguyen, J. D., Risbrough, V. B., Taffe, M. A., & Telese, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108495 · Cited by 18
Epidemiology of cannabidiol related cases reported in the National Poison Data System – 2019-2020
Berger, B. A., Stolz, U., Colvin, J. M., & Otten, E. J. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.04.065 · Cited by 21
Synthesis of the Cannabimovone and Cannabifuran Class of Minor Phytocannabinoids and Their Anti-inflammatory Activity
Dennis, D. G., Anand, S. D., Lopez, A. J., Petrovčič, J., Das, A., & Šarlah, D. (2022) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c00336 · Cited by 21
Effect profile of paracetamol, Δ9‐ THC and promethazine using an evoked pain test battery in healthy subjects
van Amerongen, G., Siebenga, P. S., de Kam, M. L., Hay, J. L., & Groeneveld, G. J. (2018) · European Journal of Pain · doi:10.1002/ejp.1222 · Cited by 21
Early Exposure to THC Alters M-Cell Development in Zebrafish Embryos
Amin, M. R., Ahmed, K. T., & Ali, D. W. (2020) · Biomedicines · doi:10.3390/biomedicines8010005 · Cited by 21
Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis
Meffert, B. N., Morabito, D. M., Mosich, M. K., Loflin, M., Sottile, J. E., & Heinz, A. J. (2018) · Current Drug Research Reviews · doi:10.2174/2589977511666181109153958 · Cited by 22
The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration
Izgelov, D., Domb, A. J., & Hoffman, A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105313 · Cited by 20
Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?
Johal, H. S., Vannabouathong, C., Chang, Y., Zhu, M. T., & Bhandari, M. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20937968 · Cited by 20
Mechanisms of cannabis impairment: Implications for modeling driving performance
Burt, T. S., Brown, T. L., Milavetz, G., & McGehee, D. V. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110902 · Cited by 20
A New Paradigm Shift in Gastroparesis Management
Mekaroonkamol, P., Tiankanon, K., & Rerknimitr, R. (2022) · Gut and Liver · doi:10.5009/gnl210309 · Cited by 20
A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History
Berl, V., Hurd, Y. L., Lipshutz, B. H., Roggen, M., Mathur, E. J., & Evans, M. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0176 · Cited by 20
Strategies for enhancing the oral bioavailability of cannabinoids
Bar-Hai, A., Domb, A. J., & Hoffman, A. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2099837 · Cited by 21
Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis
Jelínek, P., Roušarová, J., Ryšánek, P., Ježková, M., Havlůjová, T., Pozniak, J., Kozlík, P., Křížek, T., Kučera, T., Šíma, M., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0176 · Cited by 20
Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders
Kolesárová, M., Simko, P., Urbanská, N., & Kisková, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010204 · Cited by 20
Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs
Herdegen, T., & Cascorbi, I. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0223 · Cited by 20
Investigation of Cannabinoid Acid/Cyclodextrin Inclusion Complex for Improving Physicochemical and Biological Performance
Park, C., Zuo, J., Gil, M.-C., Löbenberg, R., & Lee, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112533 · Cited by 20
A Content Analysis of Cannabis Edibles Package Marketing in the United States
Reboussin, B., Lazard, A. J., Ross, J. C., Sutfin, E., Romero-Sandoval, E., Suerken, C. K., Lake, S., Horton, O., Zizzi, A. R., Wagoner, E., et al. (2024) · The International journal on drug policy · doi:10.1016/j.drugpo.2024.104526 · Cited by 19
Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson's Disease
Cilia, R. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.004 · Cited by 20
New psychoactive substances: Pharmacology influencing UK practice, policy and the law
Nutt, D. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14209 · Cited by 20
Cannabis, e-cigarettes and anesthesia
Lynn, R. R., & Galinkin, J. L. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000872 · Cited by 23
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
Ragusa, G., Gómez‐Cañas, M., Morales, P., Rodríguez‐Cueto, C., Pazos, M. R., Asproni, B., Cichero, E., Fossa, P., Pinna, G. A., Jagerovic, N., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.01.002 · Cited by 20
Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action
Swenson, K. S. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00274-y · Cited by 20
Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide
Hassenberg, C., Clausen, F., Hoffmann, G., Studer, A., & Schürenkamp, J. (2020) · International Journal of Legal Medicine · doi:10.1007/s00414-020-02387-w · Cited by 19
Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
Vázquez, M., García‐Carnelli, C., Maldonado, C., & Fagiolino, P. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_3 · Cited by 24
Form and content of Jamaican cannabis edibles
Lindsay, C. M., Abel, W. D., Jones-Edwards, E. E., Brown, P. D., Bernard, K. K., & Taylor, T. T. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00079-9 · Cited by 19
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Laudański, K., & Wain, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030558 · Cited by 22
Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department
Mohammad, R., Exadaktylos, A. K., Santa, V. D., & Heymann, E. P. (2022) · International Journal of Emergency Medicine · doi:10.1186/s12245-022-00446-0 · Cited by 21
Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives
Silva-Cardoso, G. K., & Leite‐Panissi, C. R. A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0096 · Cited by 22
Pharmacokinetics and pharmacodynamics of cannabis‐based medicine in a patient population included in a randomized, placebo‐controlled, clinical trial
Hansen, J. S., Boix, F., Hasselstrøm, J. B., Sørensen, L. K., Kjølby, M., Gustavsen, S., Hansen, R. M., Petersen, T., Sellebjerg, F. T., Kasch, H., et al. (2023) · Clinical and Translational Science · doi:10.1111/cts.13685 · Cited by 19
Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Safi, K., Sobieraj, J., Błaszkiewicz, M., Żyła, J., Salata, B., & Dzierżanowski, T. (2024) · Biomedicines · doi:10.3390/biomedicines12020307 · Cited by 21
Formulation and Chemical Stability in Aqueous Media of Cannabidiol Embedded in Cardanol-Based Nanovesicles
Bello, M. P. D., Bloise, E., Mazzetto, S. E., & Mele, G. (2017) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.7b01658 · Cited by 19
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer
Lucas, C. J., Galettis, P., Shuzhen, S., Solowij, N., Reuter, S. E., Schneider, J., & Martin, J. H. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.12.008 · Cited by 19
Cannabinoid treats as adjunctive therapy for pets: gaps in our knowledge
Greb, A. C., & Puschner, B. (2018) · Toxicology Communications · doi:10.1080/24734306.2018.1434470 · Cited by 19
Rhodium-catalyzed asymmetric intramolecular hydroarylation of allenes: access to functionalized benzocycles
Berthold, D., Klett, J., & Breit, B. (2019) · Chemical Science · doi:10.1039/c9sc03894a · Cited by 19
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review
Mun, C. J., Letzen, J. E., Peters, E. N., Campbell, C. M., Vandrey, R. G., Gajewski-Nemes, J., DiRenzo, D., Caufield-Noll, C. P., & Finan, P. H. (2019) · Pain · doi:10.1097/j.pain.0000000000001720 · Cited by 21
THC detection in the breath
Ramzy, V., & Priefer, R. (2020) · Talanta · doi:10.1016/j.talanta.2020.121528 · Cited by 19
Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers
Hoffman, M. A., Hubbard, J. A., Sobolesky, P. M., Smith, B. E., Suhandynata, R. T., Sanford, S., Sones, E. G., Ellis, S., Umlauf, A., Huestis, M. A., et al. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab078 · Cited by 19
Self-citation
A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer’s Disease across a Decade of Research
Tyrakis, P., Agridi, C., & Kourti, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168630 · Cited by 19
Cannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adults
Berg, C. J., LoParco, C. R., Romm, K. F., Cui, Y., McCready, D. M., Wang, Y., Yang, Y. T., Szlyk, H. S., Kasson, E. M., Chakraborty, R., et al. (2025) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-025-00634-0 · Cited by 19
Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation
Hermush, V., Mizrahi, N., Tal, B., & Ezra, R. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00294-8 · Cited by 18
Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis
Gustavsen, S., Søndergaard, H. B., Línnet, K., Thomsen, R., Rasmussen, B. S., Sørensen, P. S., Sellebjerg, F. T., & Oturai, A. B. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102708 · Cited by 18
Cannabidiol Modulates Mitochondrial Redox and Dynamics in MCF7 Cancer Cells: A Study Using Fluorescence Lifetime Imaging Microscopy of NAD(P)H
Mould, R. R., Botchway, S. W., Parkinson, J. R. C., Thomas, E. L., Guy, G. W., Bell, J. D., & Nunn, A. V. W. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.630107 · Cited by 20
Fast and highly sensitive determination of tetrahydrocannabinol (THC) metabolites in hair using liquid chromatography‐multistage mass spectrometry (LC–MS 3 )
Hehet, P., Franz, T., Kunert, N., & Mußhoff, F. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3330 · Cited by 18
Chitosan-Coated Alginate Microcapsules of a Full-Spectrum Cannabis Extract: Characterization, Long-Term Stability and In Vitro Bioaccessibility
Villate, A., Nicolás, M. S., Olivares, M., Aizpurua‐Olaizola, O., & Usobiaga, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030859 · Cited by 18
Argentination: A Silver Bullet for Cannabinoid Separation by Differential Mobility Spectrometry
Ieritano, C., Thomas, P., & Hopkins, W. S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01241 · Cited by 18
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats
Calik, M. W., & Carley, D. W. (2016) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-016-0052-1 · Cited by 18
Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
Zhou, T., Ahmad, T. K., Alrushaid, S., Pozdirca, M., Ethans, K. D., Intrater, H. M., Le, T. S., Burczynski, F. J., Kong, J., & Namaka, M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.033 · Cited by 18
Cannabis-based medicines for chronic pain management
Sharon, H., & Brill, S. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000775 · Cited by 18
Medical Cannabis for the Primary Care Physician
Slawek, D. E., Meenrajan, S. R., Alois, M., Barker, P. C., Estores, I. M., & Cook, R. L. (2019) · Journal of Primary Care & Community Health · doi:10.1177/2150132719884838 · Cited by 19
Development of cannabidiol as a treatment for severe childhood epilepsies
Williams, C. M., & Stephens, G. J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15274 · Cited by 18
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
Tănăsescu, R., & Constantinescu, C. S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.795542 · Cited by 18
Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults
Ngueta, G., & Ndjaboué, R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12958 · Cited by 19
Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis
Mathur, K., Vuppalanchi, V., Gelow, K., Vuppalanchi, R., & Lammert, C. S. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05756-7 · Cited by 17
Unintentional cannabis poisoning in toddlers: A one year study in Marseille
Mehamha, H., Doudka, N., Minodier, P., Néant, N., Lacarelle, B., Solas, C., & Fabresse, N. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110858 · Cited by 17
The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
Nabata, K. J., Tse, E. K., Nightingale, T. E., Lee, A. H. X., Eng, J. J., Querée, M., Walter, M., & Krassioukov, A. V. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200420085712 · Cited by 18
Using the Absorption Cocktail Approach to Assess Differential Absorption Kinetics of Cannabidiol Administered in Lipid-Based Vehicles in Rats
Izgelov, D., Regev, A., Domb, A. J., & Hoffman, A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00141 · Cited by 18
The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression.
Li, X., Diviant, J. P., Stith, S. S., Brockelman, F., Keeling, K., Hall, B., & Vigil, J. M. (2020) · PubMed · Cited by 23
DNA Damaging Effects, Oxidative Stress Responses and Cholinesterase Activity in Blood and Brain of Wistar Rats Exposed to Δ9-Tetrahydrocannabinol
Kopjar, N., Fuchs, N., Žunec, S., Mikolić, A., Micek, V., Kozina, G., Vrdoljak, A. L., & Karačonji, I. B. (2019) · Molecules · doi:10.3390/molecules24081560 · Cited by 17
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study
Vulfsons, S., Ognitz, M., Bar‐Sela, G., Raz‐Pasteur, A., & Eisenberg, E. (2019) · Palliative & Supportive Care · doi:10.1017/s147895151900021x · Cited by 17
Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence
Schuster, R. M., Potter, K. W., Vandrey, R. G., Hareli, M., Gilman, J. M., Schoenfeld, D., & Evins, A. E. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119872206 · Cited by 17
Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users
Mørland, J. G., & Bramness, J. G. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110188 · Cited by 17
Investigation of cannabidiol gastro retentive tablets based on regional absorption of cannabinoids in rats
Izgelov, D., Freidman, M., & Hoffman, A. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.05.010 · Cited by 17
Cannabis and the liver: Things you wanted to know but were afraid to ask
Zhu, J., & Peltekian, K. M. (2019) · Canadian Liver Journal · doi:10.3138/canlivj.2018-0023 · Cited by 17
Implications of dysregulated endogenous cannabinoid family members in the pathophysiology of endometriosis
Lingegowda, H., Miller, J. E., McCallion, A., Childs, T. J., Lessey, B. A., Koti, M., & Tayade, C. (2021) · F&S Science · doi:10.1016/j.xfss.2021.09.005 · Cited by 16
Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development
Schultz, H. B., Hosseini, A., McLachlan, A. J., & Reuter, S. E. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0202 · Cited by 16
Marijuana use and DNA methylation-based biological age in young adults
Nannini, D. R., Zheng, Y., Joyce, B. T., Gao, T., Liu, L., Jacobs, D. R., Schreiner, P. J., Liu, C., Horvath, S., Lu, A. T.-H., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01359-8 · Cited by 16
The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower
Plumb, J., Demirel, S., Sackett, J., Russo, E. B., & Wilson-Poe, A. R. (2022) · Psychoactives · doi:10.3390/psychoactives1020008 · Cited by 14
Evidence of 11-Hydroxy-hexahydrocannabinol and 11-Nor-9-carboxy-hexahydrocannabinol as Novel Human Metabolites of Δ9-Tetrahydrocannabinol
Jørgensen, C. F., Rasmussen, B. S., Línnet, K., & Thomsen, R. (2023) · Metabolites · doi:10.3390/metabo13121169 · Cited by 16
Elucidating the Mechanism of Metabolism of Cannabichromene by Human Cytochrome P450s
Roy, P., Maturano, J., Hasdemir, H. S., Lopez, A. F., Xu, F., Hellman, J., Tajkhorshid, E., Šarlah, D., & Das, A. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00336 · Cited by 17
Development, Characterization and In Vitro Gastrointestinal Release of PLGA Nanoparticles Loaded with Full-Spectrum Cannabis Extracts
Villate, A., Barreto, G. P., Nicolás, M. S., Aizpurua‐Olaizola, O., Olivares, M., & Usobiaga, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02836-4 · Cited by 16
Supplementation of Saussurea costus root alleviates sodium nitrite-induced hepatorenal toxicity by modulating metabolic profile, inflammation, and apoptosis
Elshaer, S. E., Hamad, G. M., Sobhy, S. E., Darwish, A. M. G., Baghdadi, H. H., Nahas, H. H. A., El-Demerdash, F. M., Kabeil, S. S. A., Altamimi, A. S. A., Al-Olayan, E. M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1378249 · Cited by 18
Cannabidiol—A friend or a foe?
Tihăuan, B.-M., Onisei, T., Slootweg, W., Gună, D., Iliescu, C., & Chifiriuc, M. C. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107036 · Cited by 16

Authors: Huestis, M. A.
Affiliations: National Institutes of Health (US)
Corresponding author: Huestis, Marilyn A.
ORCID: Huestis, Marilyn A.
Venue: Chemistry & Biodiversity
Publisher: Wiley
Published: 2007-08
Volume: 4
Issue: 8
Pages: 1770-1804
ISSN: 1612-1872 (ISSN-L)
1612-1880
DOI: 10.1002/cbdv.200790152
PMC: PMC2689518
OpenAlex: W2169754532
Cited by: 1,102
References: 173
Citations by year: 2026: 79 · 2025: 97 · 2024: 77 · 2023: 114 · 2022: 109 · 2021: 121 · 2020: 132 · 2019: 117 · 2018: 70 · 2017: 56 · 2016: 42 · 2015: 31 · 2014: 14 · 2013: 13 · 2012: 10
FWCI: 0.35
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 20 d)
Locations: Chemistry & Biodiversity (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute on Drug Abuse (Z01DA000413, Z01DA000415, Z01DA000412)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: cannabinoids, pharmacokinetics, human metabolism, drug absorption, distribution, metabolism, excretion
MeSH terms: Cannabinoids, Humans, Sweat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human Cannabinoid Pharmacokinetics

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks